Category Archives: SSRI Antidepressants

Featured Stories

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Death in Those Taking Bactrim with ACE Inhibitors or ARBs

Sudden Death in Those Taking Bactrim Along with ACE Inhibitors or ARBs

Association between sudden death in those given Bactrim while already taking renin-angiotensin system blockers angiotensin receptor blockers (ARBs), heart medications.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

For some of the millions of people worldwide who take selective serotonin re-uptake inhibitors (SSRIs) to treat depression, the drug may actually increase the patient’s fear and anxiety. This family of widely prescribed drugs includes Prozac (fluoxetine) and Zoloft (sertraline). … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants | Tagged , , , , , , , , , , , , , |

Forest Laboratories Denies Claims in Antidepressant Drug Multidistrict Litigation

  Forest Laboratories is facing claims in a multidistrict litigation (MDL) that alleges it misrepresented the efficacy of the antidepressant drugs Lexapro and Celexa for the treatment of depression in pediatric patients. Forest countered telling the Massachusetts federal court that … Continue reading

Posted in Consumer Fraud, Health Concerns, Pharmaceuticals, SSRI Antidepressants |

New Study Warns of Increased Bleeding Risk In Patients with Combined Use of Antidepressants and NSAIDs

Combining Antidepressants & NSAIDs Cause Bleeding Risks

Results of a new study from a research team in Korea indicate that the combined use of antidepressants and nonsteroidal anti-inflammatory drugs (NSAIDs), a common form of painkiller, is associated with an increased risk of intracranial bleeding. The authors write … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants | Tagged , , , , |

Following Husband’s Death, Widow’s Sues Over Allegedly Weak Warning Label on Generic Medication

A widow is suing the maker of  (paroxetine) tablets that her husband, 42 at the time of his death, took as prescribed in 2010. The widow alleges that just six paroxetine tablets led to her husband’s suicide and did not … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

SSRI Antidepressant Use in Pregnancy Tied to Autism Risk

A new study reports that boys with autism were three times more likely to have been exposed to SSRI antidepressants (selective serotonin reuptake inhibitors)  in the womb than typically developing children. Boys whose mothers took SSRIs – including Celexa (citalopram), … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Maternal Use of SSRI Antidepressants Linked to Pulmonary Hypertension in Newborns

ssri-antidepressants-newborn-hypertension

New research shows that maternal use of SSRI antidepressants late in pregnancy is linked to increased risk for persistent pulmonary hypertension (PPH) in newborns. A meta-analysis of seven studies shows a significant association between PPH – increased pressure in the pulmonary arteries – in infants whose … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Adipotrim XT Dietary Supplement Recalled for Undeclared Drug Ingredient

adipotrim-xt-supplement-recall

Deseo Rebajar Inc., is voluntarily recalling Adipotrim XT, a dietary supplement sold directly to customers in Fajardo, Caguas and Bayamon, Puerto Rico, and online. A U.S. Food and Drug Administration (FDA) laboratory analysis found it to contain undeclared fluoxetine, a selective … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, SSRI Antidepressants |

Study: SSRIs Use Tied to Upper GI Bleeds

ssri_tied_to_gi_tract_bleeding

The use of selective serotonin reuptake inhibitors (SSRIs) for as little as seven days presents significant increased risks for upper gastrointestinal (GI) bleeding events, according to a new study. “Consistent with previous studies, SSRIs were the only antidepressants found to … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

Study: Certain Antidepressants Linked to Increased Clostridium Difficile Risks

antidepressants-Clostridium-difficile-infections

The antidepressants mirtazapine—sold under the brands Remeron, Avanza, and Zispin—and fluoxetine (known as Prozac, Sarafem, or Fontex) have been associated with an increased risk Clostridium difficile infection (CDI), according to new research. Investigators at the University of Michigan in Ann … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

JAMA Study: Perioperative SSRI Use Associated with Increased Adverse Event Risks

SSRI-Adverse_Effects

A new study found that patients taking selective serotonin reuptake inhibitors (SSRIs) during the perioperative period (from hospitalization admission to discharge) were at increased risks for suffering an adverse event. The study appears in the April 29, 2013 issue of … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.